Ann: CEO presentation to Broker Meets Biotech - Perth, page-64

I would have to lean toward Super Tramps analogy , Big Pharma Monitor nearly all Phase I and II Trials , they already have a complete understanding of the Trial perimeters and what the Primary Endpoint claim is ,, Confirmation of results is all they require... Many Big Pharma deals come ready for signature , price point defined and terms that these megaliths don't vary from, mostly mandated terms already established by the Board.

There is a good example recently of one ASX Baby Bio who posted interim results and Big Pharma came in with $15m to fund Phase III,,on interim results,, no discussion , 3 days downtime and bang back up trading with a very healthy bank balance..

Don't think for a second big pharma aren't concerned about anything they will dent their current income,,especially Disruptive Technology... They have paid professionals monitoring the market constantly, especially in the past year as Big Pharma reduce the internal spend on R and D preferring to lolly pick the best when Risk is mitigated by success ,